Cargando…

T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY

BACKGROUND: Evidence on physiological roles of AMPA receptors in psychiatric conditions, including schizophrenia, has been accumulated, which mainly derives from psychiatric disease model animals as well as post-mortem brain tissues. However, its clinical translation was limited due to lack of any t...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Hiroyuki, Miyazaki, Tomoyuki, Nakajima, Waki, Hatano, Mai, Tani, Hideaki, Nagai, Nobuhiro, Koizumi, Teruki, Nakajima, Shinichiro, Mimura, Masaru, Takahashi, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234628/
http://dx.doi.org/10.1093/schbul/sbaa029.726
_version_ 1783535808272138240
author Uchida, Hiroyuki
Miyazaki, Tomoyuki
Nakajima, Waki
Hatano, Mai
Tani, Hideaki
Nagai, Nobuhiro
Koizumi, Teruki
Nakajima, Shinichiro
Mimura, Masaru
Takahashi, Takuya
author_facet Uchida, Hiroyuki
Miyazaki, Tomoyuki
Nakajima, Waki
Hatano, Mai
Tani, Hideaki
Nagai, Nobuhiro
Koizumi, Teruki
Nakajima, Shinichiro
Mimura, Masaru
Takahashi, Takuya
author_sort Uchida, Hiroyuki
collection PubMed
description BACKGROUND: Evidence on physiological roles of AMPA receptors in psychiatric conditions, including schizophrenia, has been accumulated, which mainly derives from psychiatric disease model animals as well as post-mortem brain tissues. However, its clinical translation was limited due to lack of any tool to visualize AMPA receptors in living human brain. We have recently developed a new positron emission tomography (PET) probe for AMPA receptors (Miyazaki et al. Nature Medicine, in press). Here, we used the first PET probe that specifically binds to AMPA receptors and successfully visualized these receptors in living human brain of patients with schizophrenia. METHODS: We developed a novel PET probe for AMPARs, named [11C]K-2 (Miyazaki et al. Nature Medicine, in press). Male patients aged 30–49 with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) underwent a [11C]K-2 PET scan and an MRI scan for co-registration of the PET image and received clinical assessments for symptomatology, including the Positive and Negative Syndrome Scale (PANSS) (registration number: UMIN000025132). [11C]K-2 was synthesized at Yokohama City University Hospital in accordance with GMP ordinance and was certified by the Japanese Society of Nuclear Medicine. PET imaging was performed with a TOSHIBA Aquiduo scanner (TOSHIBA Medical), which provided an axial FOV of 240 mm, and 80 contiguous 2.0 mm thick slices. Standardized uptake value ratio (SUVR)30–50 min with the whole brain and white matter as a reference was calculated, respectively. RESULTS: Ten subjects with schizophrenia (mean±SD age, 43.1±3.1 years; duration of illness, 16.8±8.0 years; PANSS total score, 61.7±13.4) participated in this study. There were negative correlations between SUVR30-50 min with the whole brain as a reference in the cingulate gyrus and parahippocampus and PANSS total scores according to the voxel-wise analysis. These correlations were not observed when the while matter was used as a reference. DISCUSSION: [11C]K-2 has revealed distinct distribution patterns of AMPA receptors for schizophrenia. Thus, [11C]K-2 is proven to be a potent PET tracer that can be used to visualize AMPARs with high contrast, leading to the elucidation of the molecular mechanisms of schizophrenia.
format Online
Article
Text
id pubmed-7234628
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72346282020-05-23 T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY Uchida, Hiroyuki Miyazaki, Tomoyuki Nakajima, Waki Hatano, Mai Tani, Hideaki Nagai, Nobuhiro Koizumi, Teruki Nakajima, Shinichiro Mimura, Masaru Takahashi, Takuya Schizophr Bull Poster Session III BACKGROUND: Evidence on physiological roles of AMPA receptors in psychiatric conditions, including schizophrenia, has been accumulated, which mainly derives from psychiatric disease model animals as well as post-mortem brain tissues. However, its clinical translation was limited due to lack of any tool to visualize AMPA receptors in living human brain. We have recently developed a new positron emission tomography (PET) probe for AMPA receptors (Miyazaki et al. Nature Medicine, in press). Here, we used the first PET probe that specifically binds to AMPA receptors and successfully visualized these receptors in living human brain of patients with schizophrenia. METHODS: We developed a novel PET probe for AMPARs, named [11C]K-2 (Miyazaki et al. Nature Medicine, in press). Male patients aged 30–49 with schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) underwent a [11C]K-2 PET scan and an MRI scan for co-registration of the PET image and received clinical assessments for symptomatology, including the Positive and Negative Syndrome Scale (PANSS) (registration number: UMIN000025132). [11C]K-2 was synthesized at Yokohama City University Hospital in accordance with GMP ordinance and was certified by the Japanese Society of Nuclear Medicine. PET imaging was performed with a TOSHIBA Aquiduo scanner (TOSHIBA Medical), which provided an axial FOV of 240 mm, and 80 contiguous 2.0 mm thick slices. Standardized uptake value ratio (SUVR)30–50 min with the whole brain and white matter as a reference was calculated, respectively. RESULTS: Ten subjects with schizophrenia (mean±SD age, 43.1±3.1 years; duration of illness, 16.8±8.0 years; PANSS total score, 61.7±13.4) participated in this study. There were negative correlations between SUVR30-50 min with the whole brain as a reference in the cingulate gyrus and parahippocampus and PANSS total scores according to the voxel-wise analysis. These correlations were not observed when the while matter was used as a reference. DISCUSSION: [11C]K-2 has revealed distinct distribution patterns of AMPA receptors for schizophrenia. Thus, [11C]K-2 is proven to be a potent PET tracer that can be used to visualize AMPARs with high contrast, leading to the elucidation of the molecular mechanisms of schizophrenia. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234628/ http://dx.doi.org/10.1093/schbul/sbaa029.726 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Session III
Uchida, Hiroyuki
Miyazaki, Tomoyuki
Nakajima, Waki
Hatano, Mai
Tani, Hideaki
Nagai, Nobuhiro
Koizumi, Teruki
Nakajima, Shinichiro
Mimura, Masaru
Takahashi, Takuya
T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
title T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
title_full T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
title_fullStr T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
title_full_unstemmed T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
title_short T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
title_sort t166. visualization of ampa receptors in patients with schizophrenia and depression: the first pet imaging study
topic Poster Session III
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234628/
http://dx.doi.org/10.1093/schbul/sbaa029.726
work_keys_str_mv AT uchidahiroyuki t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy
AT miyazakitomoyuki t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy
AT nakajimawaki t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy
AT hatanomai t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy
AT tanihideaki t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy
AT nagainobuhiro t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy
AT koizumiteruki t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy
AT nakajimashinichiro t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy
AT mimuramasaru t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy
AT takahashitakuya t166visualizationofampareceptorsinpatientswithschizophreniaanddepressionthefirstpetimagingstudy